Genome‐wide association study identifies new susceptibility loci for cutaneous lupus erythematosus

Cutaneous lupus erythematosus (CLE) is a chronic autoimmune disease of the skin with typical clinical manifestations. Here, we genotyped 906 600 single nucleotide polymorphisms (SNPs) in 183 CLE cases and 1288 controls of Central European ancestry. Replication was performed for 13 SNPs in 219 case subjects and 262 controls from Finland. Association was particularly pronounced at 4 loci, all with genomewide significance (P < 5 × 10−8): rs2187668 (PGWAS = 1.4 × 10−12), rs9267531 (PGWAS = 4.7 × 10−10), rs4410767 (PGWAS = 1.0 × 10−9) and rs3094084 (PGWAS = 1.1 × 10−9). All mentioned SNPs are located within the major histocompatibility complex (MHC) region of chromosome 6 and near genes of known immune functions or associations with other autoimmune diseases such as HLA‐DQ alpha chain 1 (HLA‐DQA1), MICA, MICB, MSH5, TRIM39 and RPP21. For example, TRIM39/RPP21 read through transcript is a known mediator of the interferon response, a central pathway involved in the pathogenesis of CLE and systemic lupus erythematosus (SLE). Taken together, this genomewide analysis of disease association of CLE identified candidate genes and genomic regions that may contribute to pathogenic mechanisms in CLE via dysregulated antigen presentation (HLA‐DQA1), apoptosis regulation, RNA processing and interferon response (MICA, MICB, MSH5, TRIM39 and RPP21).

[1]  M. Haust,et al.  Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus , 2010, The British journal of dermatology.

[2]  Liangdan Sun,et al.  TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population , 2010, Lupus.

[3]  Wentian Li,et al.  STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. , 2007, The New England journal of medicine.

[4]  A. Kuhn,et al.  The classification and diagnosis of cutaneous lupus erythematosus. , 2014, Journal of autoimmunity.

[5]  J. McGregor,et al.  Molecular genetics of cutaneous lupus erythematosus , 2001, Clinical and experimental dermatology.

[6]  J. Kere,et al.  Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus , 2010, Experimental dermatology.

[7]  P. Gaffney,et al.  Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. , 2011, Arthritis and rheumatism.

[8]  Peter K Gregersen,et al.  Recent advances in the genetics of autoimmune disease. , 2009, Annual review of immunology.

[9]  Phillip A Sharp,et al.  A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. , 2012, Genes & development.

[10]  V. Bini,et al.  Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. , 2005, Rheumatology.

[11]  C. Langefeld,et al.  Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. , 2010, Arthritis and rheumatism.

[12]  Pardis C Sabeti,et al.  Identification of Two Independent Risk Factors for Lupus within the MHC in United Kingdom Families , 2007, PLoS genetics.

[13]  P. Onkamo,et al.  LUPUS AROUND THE WORLD Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations , 2008 .

[14]  N. Fu,et al.  TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process. , 2009, Experimental cell research.

[15]  Liangdan Sun,et al.  Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus , 2011, Rheumatology International.

[16]  A. Syvänen,et al.  Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus , 2011, PLoS genetics.

[17]  M. Kimura,et al.  Structure of an archaeal homolog of the human protein complex Rpp21-Rpp29 that is a key core component for the assembly of active ribonuclease P. , 2008, Journal of Molecular Biology.

[18]  A. Sinha,et al.  Cutaneous lupus erythematosus: Understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies , 2006, Autoimmunity.

[19]  Y. Ben-Asouli,et al.  Eukaryotic RNase P: role of RNA and protein subunits of a primordial catalytic ribonucleoprotein in RNA-based catalysis. , 2003, Molecular cell.

[20]  T. Horiuchi,et al.  Role of the MICA polymorphism in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[21]  C. Günther,et al.  Aicardi–Goutières syndrome: a model disease for systemic autoimmunity , 2014, Clinical and experimental immunology.

[22]  Geoffrey Hom,et al.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. , 2008, The New England journal of medicine.

[23]  G. van Loo,et al.  The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. , 2009, Trends in immunology.

[24]  J. Kere,et al.  Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population. , 2012, Rheumatology.

[25]  Hyung-Sik Kang,et al.  Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[26]  S. Dovat,et al.  Ikaros and tumor suppression in acute lymphoblastic leukemia. , 2011, Critical reviews in oncogenesis.

[27]  M. Bijl,et al.  Pathogenesis of cutaneous lupus erythematosus , 2008, Lupus.

[28]  T. Ruzicka,et al.  Classification of Cutaneous Lupus Erythematosus , 2005 .

[29]  T. Vyse,et al.  The genetics of lupus: a functional perspective , 2012, Arthritis Research & Therapy.

[30]  A. Kuhn,et al.  Photosensitivity, Apoptosis, and Cytokines in the Pathogenesis of Lupus Erythematosus: a Critical Review , 2014, Clinical Reviews in Allergy & Immunology.

[31]  J. Wenzel,et al.  Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches , 2007, Experimental dermatology.

[32]  C. Kallenberg,et al.  Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. , 2011, Clinical immunology.

[33]  J. Kere,et al.  Polymorphisms of the ITGAM Gene Confer Higher Risk of Discoid Cutaneous Than of Systemic Lupus Erythematosus , 2010, PloS one.

[34]  L. Kiemeney,et al.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. , 2011, The New England journal of medicine.

[35]  R. Naumann,et al.  Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity , 2012, The Journal of experimental medicine.

[36]  Marta E Alarcón-Riquelme,et al.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.

[37]  A. Davidson,et al.  Taming lupus—a new understanding of pathogenesis is leading to clinical advances , 2012, Nature Medicine.

[38]  S. Kornbluth,et al.  The Trim39 ubiquitin ligase inhibits APC/CCdh1-mediated degradation of the Bax activator MOAP-1 , 2012, The Journal of Cell Biology.

[39]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[40]  F. Toberer,et al.  Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray , 2013, Experimental dermatology.

[41]  A. Aderem,et al.  TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE , 2006, The Journal of Experimental Medicine.

[42]  D. Wieczorek,et al.  Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. , 2010, Arthritis and rheumatism.

[43]  D. Nemazee,et al.  Deletion of IgG-Switched Autoreactive B Cells and Defects in Faslpr Lupus Mice , 2010, The Journal of Immunology.

[44]  Annette Lee,et al.  Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G , 2012, Annals of the rheumatic diseases.

[45]  J. Kere,et al.  Familial systemic lupus erythematosus in Finland. , 2001, The Journal of rheumatology.

[46]  F. Takeuchi,et al.  The genetic contribution of HLA‐DRB5*01:01 to systemic lupus erythematosus in Thailand , 2013, International journal of immunogenetics.

[47]  P. Gaffney,et al.  Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. , 2012, American journal of human genetics.

[48]  H. Inoko,et al.  TRIM39 and RNF39 are associated with Behçet's disease independently of HLA-B∗51 and -A∗26. , 2010, Biochemical and Biophysical Research Communications - BBRC.

[49]  D. Geraghty,et al.  A second lineage of mammalian major histocompatibility complex class I genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Bank,et al.  Multiple hematopoietic defects and delayed globin switching in Ikaros null mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Sticherling,et al.  Clinical Manifestations of Cutaneous Lupus Erythematosus , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[52]  P. Gregersen,et al.  Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. , 2012, American journal of human genetics.

[53]  A. Krieg,et al.  Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity , 2007, Immunological reviews.

[54]  G. Tsujimoto,et al.  Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. Novota,et al.  HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population , 2011, Rheumatology International.

[56]  David Altshuler,et al.  Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[57]  R. Maul,et al.  Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response , 2012, Genes and Immunity.

[58]  S. Lei,et al.  Functional Relevance for Associations between Genetic Variants and Systemic Lupus Erythematosus , 2013, PloS one.

[59]  P. Gaffney,et al.  High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions , 2009, PLoS genetics.

[60]  H. Inoko,et al.  TRIM39R, but not TRIM39B, regulates type I interferon response. , 2013, Biochemical and biophysical research communications.

[61]  Pui-Yan Kwok,et al.  Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus , 2008, Nature Genetics.

[62]  J. Goust,et al.  Systemic lupus erythematosus. , 1976, Immunology series.

[63]  M. Hochberg,et al.  The application of genetic epidemiology to systemic lupus erythematosus. , 1987, The Journal of rheumatology.

[64]  W. J. Morginson.  [Lupus erythematosus]. , 1960, Revista medica hondurena.

[65]  Jeanine J. Houwing-Duistermaat,et al.  Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers , 2013, PLoS genetics.